INNOVATE BIOPHARMACEUTICLS I's ticker is and the CUSIP is 45782F905. A total of 3 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $26,000 | +188.9% | 52,000 | +519.0% | 0.00% | – |
| Q3 2019 | $9,000 | -35.7% | 8,400 | -31.7% | 0.00% | – |
| Q2 2019 | $14,000 | -83.3% | 12,300 | -71.8% | 0.00% | -100.0% |
| Q1 2019 | $84,000 | +189.7% | 43,600 | +248.8% | 0.00% | – |
| Q4 2018 | $29,000 | -94.0% | 12,500 | -82.2% | 0.00% | -100.0% |
| Q3 2018 | $481,000 | -13.5% | 70,400 | +198.3% | 0.00% | -20.0% |
| Q2 2018 | $556,000 | – | 23,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 43,600 | $84,000 | 0.00% |
| SIMPLEX TRADING, LLC | 30 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |